Oct 14, 2016 11:35 am UTC| Business
NEW YORK, Oct. 14, 2016 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive...
Oct 14, 2016 11:30 am UTC| Business
Top-line IGNITE4 Data Expected in 4Q 2017 Results to Support NDA Filing for IV Eravacycline in cIAI WATERTOWN, Mass., Oct. 14, 2016 -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced dosing of the...
SPX to Report Third Quarter 2016 Financial Results on November 3th
Oct 14, 2016 11:30 am UTC| Business
CHARLOTTE, N.C., Oct. 14, 2016 -- SPX Corporation (NYSE:SPXC) announced today that it will release its third quarter 2016 financial results after market close on Thursday, November 3, 2016. SPX Corporation President...
National Interstate Corporation Announces Timing of Third Quarter Earnings Release
Oct 14, 2016 11:30 am UTC| Business
RICHFIELD, Ohio, Oct. 14, 2016 -- National Interstate Corporation (Nasdaq:NATL) announced today that the Company expects to release its 2016 third quarter results after the market closes on Tuesday, November 1, 2016....
Oxford Announces Webcast of 2016 Investor Day
Oct 14, 2016 11:30 am UTC| Business
ATLANTA, Oct. 14, 2016 -- Oxford Industries, Inc. (NYSE:OXM) today announced that it will webcast its 2016 Investor Day on Tuesday, October 18, 2016 beginning at 3:00 p.m. ET. The event, to be held in New York City,...
Adverum Biotechnologies Provides Update on Alpha-1 Antitrypsin Deficiency Program
Oct 14, 2016 11:01 am UTC| Business
MENLO PARK, Calif., Oct. 14, 2016 -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM) today provided an update on its development program for ADVM-043 (formerly “ANN-001”), a novel gene therapy for Alpha-1 Antitrypsin (A1AT)...
Adverum Biotechnologies, Inc. Announces New Executive Chair and CEO
Oct 14, 2016 11:00 am UTC| Business
Paul Cleveland Named Executive Chairman of the Board Amber Salzman, Ph.D. Named CEO MENLO PARK, Calif., Oct. 14, 2016 -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a gene therapy company committed to...